Prestige Brand Holdings Inc

Healthcare · Drug Manufacturers - Specialty & Generic

46.40$ +1.8% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Income Statement

Prestige Brand Holdings Inc (PBH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 266 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement PBH
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	215	217	241	257	258	271	256	254	239	241	241	232	238	242	251	229	237	239	238	269	276	274	267	277	289	276	286	279	286	283	277	267	284	290	297	250	274	283	282	266	1,105
Cost of Revenue	91	92	110	113	114	123	115	113	102	102	103	98	101	104	107	96	100	100	101	110	119	119	118	117	128	125	132	125	126	125	125	121	126	129	121	114	120	126	141	130	516
Gross Profit	124	125	130	143	144	148	141	141	137	139	138	134	137	137	144	134	138	139	137	159	158	155	149	160	161	150	154	155	160	158	152	146	157	161	176	135	154	157	141	136	588
Research & Development	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Selling, General & Administrative	19	22	29	20	22	21	122	24	24	20	21	22	23	21	24	20	20	21	24	22	32	26	28	27	26	27	28	28	26	26	26	29	26	26	27	28	28	30	30	43	131
Total Operating Expenses	53	59	77	64	68	64	164	68	68	62	62	63	67	61	70	54	65	65	66	68	79	72	71	73	77	63	435	69	72	71	70	74	73	69	87	63	74	75	65	84	298
Operating Income	71	69	53	79	76	84	-23	72	71	78	-153	71	69	76	74	80	73	73	71	91	79	83	77	87	84	87	-281	85	88	87	82	72	84	92	88	72	80	82	75	53	290
Interest Expense	21	19	33	26	27	26	27	26	27	26	26	25	25	25	22	22	21	20	19	15	16	17	16	15	17	18	19	18	18	17	15	13	12	11	11	10	10	11	11	14	46
Pre-Tax Income	50	51	19	53	49	58	-53	46	44	51	-179	46	44	51	51	58	52	54	40	76	60	65	61	71	67	68	-300	69	70	70	67	58	72	80	74	62	69	62	65	39	234
Income Tax Expense	18	19	7.7	19	19	-257	-13	12	13	13	-40	12	11	12	13	14	7.3	13	4.9	19	14	15	8.9	16	16	16	-59	15	17	17	18	9.3	17	19	24	14	27	15	11	9.4	62
Net Income	32	32	11	34	31	315	-40	34	31	38	-139	34	33	38	37	44	45	41	36	58	45	50	52	55	51	52	-241	53	54	53	49	49	54	61	50	47	42	47	54	29	172
EBITDA	77	75	58	88	85	92	-18	81	78	85	-147	78	76	82	80	88	81	81	67	99	84	90	85	95	92	94	-273	94	96	94	90	80	90	98	92	80	87	80	85	61	313

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings